\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ none\ \(204\)\
\-\ multiple\\ lytic\\ lesions\\ expanding\\ the\\ cortex\\ with\\ endosteal\\ scalloping\\ and\\ linear\\ lucencies\\ without\\ soft\\ tissue\\ mass\\ or\\ periosteal\\ reaction\\.\ \(0\)\
\-\ ollier\\'s\\ disease\\,\\ enchondromatosis\ \(0\)\
\-\ chondrosarcoma\ \(79\)\
\-\ nonossifying\\ fibroma\ \(10\)\
\-\ fibrous\\ dysplasia\ \(50\)\
\-\ langerhans\\ cell\\ histiocytosis\ \(1\)\
\-\ bone\\ infarct\ \(20\)\
\-\ simple\\ bone\\ cyst\ \(7\)\
\-\ 3\\ year\\ old\\ evaluate\\ for\\ fracture\ \(1\)\
\-\ this\\ disease\\ is\\ named\\ after\\ louis\\ l\\?opold\\ ollier\\ a\\ french\\ surgeon\\ famous\\ for\\ his\\ work\\ in\\ orthopedic\\ and\\ reconstructive\\ surgery\\ in\\ late\\ 1800\\'s\\.\\ \ \(0\)\
\-\ enchondromatosis\\ most\\ frequently\\ involves\\ the\\ short\\ tubular\\ bones\\ of\\ hands\\ and\\ feet\\ as\\ well\\ as\\ long\\ bones\\ of\\ upper\\ and\\ lower\\ extremities\\.\\ \\ this\\ is\\ a\\ nonhereditary\\ abnormality\\ with\\ one\\ side\\ affected\\ more\\ severely\\.\\ lesion\\ growth\\ stabilizes\\ at\\ puberty\\.\\ most\\ lesions\\ are\\ metaphyseal\\ or\\ diaphyseal\\ however\\ there\\ can\\ be\\ growth\\ disturbance\\ if\\ the\\ lesion\\ involves\\ the\\ growth\\ plate\\.\ \(0\)\
\-\ debated\\ amount\\ of\\ increased\\ risk\\ for\\ chondrosarcoma\\;\\ however\\,\\ in\\ an\\ adult\\ long\\ bone\\ with\\ pain\\ and\\ no\\ evidence\\ of\\ fracture\\ malignancy\\ should\\ be\\ considered\\ until\\ proven\\ otherwise\\.\ \(0\)\
\-\ enchondromatosis\\ with\\ multiple\\ soft\\ tissue\\ hemangiomas\\ is\\ termed\\ maffucci\\â\\€\\™s\\ syndrome\\.\\ this\\ is\\ unilateral\\ and\\ involves\\ the\\ hands\\ and\\ feet\\,\\ and\\ carries\\ an\\ increased\\ risk\\ of\\ malignant\\ transformation\\ compared\\ to\\ ollier\\â\\€\\™s\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ollier\\:\\ 0\\.30153269307911096\ \(0\)\
\-\ enchondromatosis\\:\\ 0\\.2986338860092465\ \(0\)\
\-\ involves\\:\\ 0\\.20855233946977708\ \(0\)\
\-\ growth\\:\\ 0\\.19762995439634617\ \(0\)\
\-\ hands\\:\\ 0\\.15150836253835226\ \(0\)\
\-\ feet\\:\\ 0\\.15017426794608207\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.14651550629822907\ \(0\)\
\-\ and\\:\\ 0\\.1320689490035999\ \(0\)\
\-\ bone\\:\\ 0\\.13077402200893148\ \(0\)\
\-\ bones\\:\\ 0\\.12856683787516443\ \(0\)\
\-\ opold\\:\\ 0\\.12776404223695942\ \(0\)\
\-\ famous\\:\\ 0\\.12776404223695942\ \(0\)\
\-\ 1800\\:\\ 0\\.12776404223695942\ \(0\)\
\-\ nonhereditary\\:\\ 0\\.12776404223695942\ \(0\)\
\-\ stabilizes\\:\\ 0\\.11805627627912045\ \(0\)\
\-\ risk\\:\\ 0\\.11416804721571329\ \(0\)\
\-\ debated\\:\\ 0\\.11237759722800728\ \(0\)\
\-\ maffucci\\:\\ 0\\.11237759722800728\ \(0\)\
\-\ french\\:\\ 0\\.10834851032128151\ \(0\)\
\-\ long\\:\\ 0\\.10595269876839886\ \(0\)\
\-\ named\\:\\ 0\\.10388845569391951\ \(0\)\
\-\ disease\\:\\ 0\\.1006069518687769\ \(0\)\
\-\ reconstructive\\:\\ 0\\.10051089769303698\ \(0\)\
\-\ puberty\\:\\ 0\\.09864074436344256\ \(0\)\
\-\ disturbance\\:\\ 0\\.09864074436344256\ \(0\)\
\-\ carries\\:\\ 0\\.09864074436344256\ \(0\)\
\-\ diaphyseal\\:\\ 0\\.09551554176302307\ \(0\)\
\-\ however\\:\\ 0\\.09457295896972719\ \(0\)\
\-\ louis\\:\\ 0\\.09418068973608056\ \(0\)\
\-\ termed\\:\\ 0\\.09355812742961271\ \(0\)\
\-\ nonossifying\\:\\ 0\\.09239033916260359\ \(0\)\
\-\ lesions\\:\\ 0\\.09176529092336018\ \(0\)\
\-\ fracture\\:\\ 0\\.09081028848371285\ \(0\)\
\-\ expanding\\:\\ 0\\.09080313173519802\ \(0\)\
\-\ endosteal\\:\\ 0\\.09031166566647031\ \(0\)\
\-\ is\\:\\ 0\\.0875154170255349\ \(0\)\
\-\ hemangiomas\\:\\ 0\\.08728338626121619\ \(0\)\
\-\ scalloping\\:\\ 0\\.08689965415299608\ \(0\)\
\-\ increased\\:\\ 0\\.08640314414913658\ \(0\)\
\-\ severely\\:\\ 0\\.0858077758051841\ \(0\)\
\-\ lucencies\\:\\ 0\\.08512445268408483\ \(0\)\
\-\ soft\\:\\ 0\\.08506516312343698\ \(0\)\
\-\ langerhans\\:\\ 0\\.08385036147177376\ \(0\)\
\-\ metaphyseal\\:\\ 0\\.08385036147177376\ \(0\)\
\-\ tissue\\:\\ 0\\.08381865304288083\ \(0\)\
\-\ most\\:\\ 0\\.08315600362882451\ \(0\)\
\-\ this\\:\\ 0\\.08235656547045762\ \(0\)\
\-\ transformation\\:\\ 0\\.081604707210103\ \(0\)\
\-\ proven\\:\\ 0\\.08060389970863135\ \(0\)\
\-\ fibroma\\:\\ 0\\.08036448625808554\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.08012909675407091\ \(0\)\
\-\ the\\:\\ 0\\.07970633361545185\ \(0\)\
\-\ of\\:\\ 0\\.07817215112519718\ \(0\)\
\-\ multiple\\:\\ 0\\.0781534292572038\ \(0\)\
\-\ surgeon\\:\\ 0\\.07757562030337722\ \(0\)\
\-\ lesion\\:\\ 0\\.07660360939737405\ \(0\)\
\-\ late\\:\\ 0\\.07541668672624587\ \(0\)\
\-\ adult\\:\\ 0\\.07369318757232585\ \(0\)\
\-\ plate\\:\\ 0\\.07325775314911454\ \(0\)\
\-\ unilateral\\:\\ 0\\.07311556567601521\ \(0\)\
\-\ for\\:\\ 0\\.07264358186859005\ \(0\)\
\-\ simple\\:\\ 0\\.07229148412582638\ \(0\)\
\-\ orthopedic\\:\\ 0\\.0708961337507924\ \(0\)\
\-\ periosteal\\:\\ 0\\.07030510319304063\ \(0\)\
\-\ tubular\\:\\ 0\\.06940845492192786\ \(0\)\
\-\ short\\:\\ 0\\.06866837769705976\ \(0\)\
\-\ reaction\\:\\ 0\\.06796545296911423\ \(0\)\
\-\ lytic\\:\\ 0\\.06729612819581247\ \(0\)\
\-\ infarct\\:\\ 0\\.06648005198782816\ \(0\)\
\-\ until\\:\\ 0\\.06648005198782816\ \(0\)\
\-\ frequently\\:\\ 0\\.0657925350215694\ \(0\)\
\-\ affected\\:\\ 0\\.06570892076840691\ \(0\)\
\-\ work\\:\\ 0\\.06513719461868113\ \(0\)\
\-\ cortex\\:\\ 0\\.06505739186256368\ \(0\)\
\-\ be\\:\\ 0\\.06481764701159894\ \(0\)\
\-\ compared\\:\\ 0\\.0645878949682317\ \(0\)\
\-\ linear\\:\\ 0\\.06435891963689867\ \(0\)\
\-\ as\\:\\ 0\\.06419057285392453\ \(0\)\
\-\ amount\\:\\ 0\\.06391190257004539\ \(0\)\
\-\ with\\:\\ 0\\.06257508717349368\ \(0\)\
\-\ considered\\:\\ 0\\.0622541654147826\ \(0\)\
\-\ evaluate\\:\\ 0\\.062124485360450864\ \(0\)\
\-\ fibrous\\:\\ 0\\.062060092852510726\ \(0\)\
\-\ dysplasia\\:\\ 0\\.06118836779295345\ \(0\)\
\-\ an\\:\\ 0\\.06110055042826729\ \(0\)\
\-\ extremities\\:\\ 0\\.06071356483839302\ \(0\)\
\-\ malignancy\\:\\ 0\\.05980968053208673\ \(0\)\
\-\ in\\:\\ 0\\.059623303119563174\ \(0\)\
\-\ abnormality\\:\\ 0\\.05811154294635488\ \(0\)\
\-\ otherwise\\:\\ 0\\.056949571255523565\ \(0\)\
\-\ malignant\\:\\ 0\\.056949571255523565\ \(0\)\
\-\ or\\:\\ 0\\.05558572202072224\ \(0\)\
\-\ side\\:\\ 0\\.0551913717259452\ \(0\)\
\-\ should\\:\\ 0\\.05212925637546678\ \(0\)\
\-\ his\\:\\ 0\\.048452322429860355\ \(0\)\
\-\ syndrome\\:\\ 0\\.04816354218232343\ \(0\)\
\-\ if\\:\\ 0\\.04641899817725284\ \(0\)\
\-\ cyst\\:\\ 0\\.04608651144565548\ \(0\)\
\-\ one\\:\\ 0\\.04574168464466263\ \(0\)\
\-\ cell\\:\\ 0\\.04570166934371136\ \(0\)\
\-\ evidence\\:\\ 0\\.04534658521937831\ \(0\)\
\-\ more\\:\\ 0\\.043869027006468685\ \(0\)\
\-\ none\\:\\ 0\\.04366024779907918\ \(0\)\
\-\ surgery\\:\\ 0\\.04295309697410921\ \(0\)\
\-\ upper\\:\\ 0\\.042692827541085235\ \(0\)\
\-\ without\\:\\ 0\\.04213980916357793\ \(0\)\
\-\ can\\:\\ 0\\.04192457458588125\ \(0\)\
\-\ lower\\:\\ 0\\.040824688934331874\ \(0\)\
\-\ after\\:\\ 0\\.03875671916996816\ \(0\)\
\-\ well\\:\\ 0\\.03868390091681784\ \(0\)\
\-\ there\\:\\ 0\\.031788615067226064\ \(0\)\
\-\ mass\\:\\ 0\\.030516454029367517\ \(0\)\
\-\ are\\:\\ 0\\.03031522433475922\ \(0\)\
\-\ at\\:\\ 0\\.030176064324503347\ \(0\)\
\-\ pain\\:\\ 0\\.028588150430563522\ \(0\)\
\-\ no\\:\\ 0\\.025979835470070843\ \(0\)\
\-\ year\\:\\ 0\\.024621014601557377\ \(0\)\
\-\ old\\:\\ 0\\.023644696793205515\ \(0\)\
\-\ to\\:\\ 0\\.01997274015888479\ \(0\)\
